Author: bonyf

Clinical evidence affirms PerioTabs® efficacy in reducing gingival inflammation
Post

Clinical evidence affirms PerioTabs® efficacy in reducing gingival inflammation

VADUZ, Liechtenstein, 26 January 2021 – PerioTabs®, bonyf’s innovative gum and teeth brushing solution, based on the company’s proprietary anti-biofilm formulation NitrAdine®, shows high efficacy in reducing gingival inflammation in periodontically affected patients wearing fixed partial dentures.  Researchers at the faculty of Dentistry, University of Medicine and Pharmacy, Timosoara, Romania studied a group of 49 patients who were instructed to brush their teeth, gums...

bonyf’s NitrAdine® disinfecting denture tablets proven to have the highest efficacy in reducing multispecies biofilm present on dentures
Post

bonyf’s NitrAdine® disinfecting denture tablets proven to have the highest efficacy in reducing multispecies biofilm present on dentures

VADUZ, Liechtenstein, 8 January 2021 – A recent study by the Dental School of the University of Sao Paulo in Brazil published in the scientific journal “Gerondontology”, reported on the efficacy of bonyf’s NitrAdine® disinfecting effervescent denture tablets (“NitrAdine® tablets”). The study compared bonyf’s NitrAdine® tablets and Fixodent’s effervescent tablets in relation to reducing pathogenic...

PerioTabs® kills coronavirus that causes COVID-19
Post

PerioTabs® kills coronavirus that causes COVID-19

VADUZ, Liechtenstein, 16 Oct 2020 – PerioTabs®, bonyf’s innovative gum and teeth brushing solution, has proven virucidal efficacy against enveloped viruses after 2 minutes of contact. The study report was issued by an independent certified laboratory in accordance with the European Standard EN 14476 on DNA vaccinia virus (the reference virus for all enveloped viruses,...